Roger Askew
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Osteoarthritis Treatment and Mechanisms, Thyroid Disorders and Treatments, Stress Responses and Cortisol, Protease and Inhibitor Mechanisms, Inflammatory mediators and NSAID effects
Most-Cited Works
- → Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis(2005)1,235 cited
- → Characterization of and osteoarthritis susceptibility in ADAMTS‐4–knockout mice(2004)281 cited
- → Double‐knockout of ADAMTS‐4 and ADAMTS‐5 in mice results in physiologically normal animals and prevents the progression of osteoarthritis(2007)214 cited
- → The Distribution of Estrogen Receptor-β mRNA in Forebrain Regions of the Estrogen Receptor-α Knockout Mouse(1997)206 cited
- → Gob-5 Contributes to Goblet Cell Hyperplasia and Modulates Pulmonary Tissue Inflammation(2006)66 cited
- → Ketohexokinase knockout mice, a model for essential fructosuria, exhibit altered fructose metabolism and are protected from diet-induced metabolic defects(2018)35 cited
- → Physiological Expression of AMPKγ2 Mutation Causes Wolff-Parkinson-White Syndrome and Induces Kidney Injury in Mice(2016)31 cited
- → Neurotensin regulation of TSH secretion in the rat(1983)12 cited
- → The effect of neurotensin on pituitary secretion of thyrotrophin and prolactin in vitro(1984)9 cited
- → Erratum: Deletion of active ADAMTS5 prevents cartilage degradation in a murine model of osteoarthritis(2007)7 cited